標(biāo)題: Titlebook: Clinical Evaluation of Antitumor Therapy; Franco M. Muggia,Marcel Rozencweig Book 1987 Springer Science+Business Media Dordrecht 1987 canc [打印本頁] 作者: 會議記錄 時間: 2025-3-21 17:06
書目名稱Clinical Evaluation of Antitumor Therapy影響因子(影響力)
書目名稱Clinical Evaluation of Antitumor Therapy影響因子(影響力)學(xué)科排名
書目名稱Clinical Evaluation of Antitumor Therapy網(wǎng)絡(luò)公開度
書目名稱Clinical Evaluation of Antitumor Therapy網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Clinical Evaluation of Antitumor Therapy被引頻次
書目名稱Clinical Evaluation of Antitumor Therapy被引頻次學(xué)科排名
書目名稱Clinical Evaluation of Antitumor Therapy年度引用
書目名稱Clinical Evaluation of Antitumor Therapy年度引用學(xué)科排名
書目名稱Clinical Evaluation of Antitumor Therapy讀者反饋
書目名稱Clinical Evaluation of Antitumor Therapy讀者反饋學(xué)科排名
作者: 按等級 時間: 2025-3-21 21:11
Animal Tumor Models for Experimental Therapy,rent purposes: experimental surgery, experimental radiotherapy, and experimental immunotherapy. By far the largest part, however, is devoted to the subject of models for chemotherapy and, more specifically, models for the screening programs that attempt to identify new cytostatic drugs.作者: 神圣不可 時間: 2025-3-22 00:27 作者: Trypsin 時間: 2025-3-22 06:20
Analysis of Clinical Trial Data,acy. In addition, it is often difficult to put the results of a study in their proper perspective due to the large differences between trials with respect to the patient population studied and variations in the definition and evaluation of end points and toxicity. When reporting the results of treatment, it is recommended to indicate [1, 2]:作者: 抑制 時間: 2025-3-22 10:33
https://doi.org/10.1007/978-1-4613-2317-4cancer; cancer treatment; chemotherapy; clinical trial; oncology; tumor作者: Vulnerary 時間: 2025-3-22 16:03 作者: Vulnerary 時間: 2025-3-22 19:32 作者: 金桌活畫面 時間: 2025-3-22 22:46
C. Frigeri,M. Tonsi,G. A. Zanettarapy under study. The methods employed should be simple, reliable, reproducible, safe, and cost-effective; they should assure a reliable first assessment of the quality of response obtained prior to proceeding to more invasive, more accurate, but more uncomfortable and riskier tests.作者: commonsense 時間: 2025-3-23 01:33
Rotors: Stress Analysis and Designacy. In addition, it is often difficult to put the results of a study in their proper perspective due to the large differences between trials with respect to the patient population studied and variations in the definition and evaluation of end points and toxicity. When reporting the results of treatment, it is recommended to indicate [1, 2]:作者: Immortal 時間: 2025-3-23 07:14
https://doi.org/10.1007/978-3-662-09786-1In this chapter we will discuss experimental toxicology of antitumor agents in the context of antitumor drug development. We will discuss first the purposes of toxicological evaluation of such agents and its value in drug development and then outline the procedures used in carrying out toxicological evaluation.作者: penance 時間: 2025-3-23 11:12
Experimental Toxicology,In this chapter we will discuss experimental toxicology of antitumor agents in the context of antitumor drug development. We will discuss first the purposes of toxicological evaluation of such agents and its value in drug development and then outline the procedures used in carrying out toxicological evaluation.作者: insipid 時間: 2025-3-23 17:46
https://doi.org/10.1007/978-1-4612-1518-9t modalities must continue at an accelerated pace. Major points of controversy exist, however, on how this should be accomplished. The points of view expressed here concerning anticancer chemotherapy represent the result of 20 years of involvement in clinical research including day-to-day working ex作者: Servile 時間: 2025-3-23 20:34 作者: Thyroid-Gland 時間: 2025-3-23 23:19
Mathematical Model of a Gas Journal Bearingidual patient’s tumor is frequently difficult to predict. In an effort to improve the therapeutic results of cytotoxic chemical therapy, attempts have been made to develop an in vitro system to predict drug sensitivity in man, much as bacterial culture and sensitivity techniques are used to tailor a作者: sacrum 時間: 2025-3-24 03:20 作者: Conclave 時間: 2025-3-24 10:07 作者: UTTER 時間: 2025-3-24 14:27 作者: CEDE 時間: 2025-3-24 16:00 作者: dominant 時間: 2025-3-24 21:57 作者: 祖?zhèn)?nbsp; 時間: 2025-3-25 02:04 作者: corn732 時間: 2025-3-25 05:36
Lech Polkowski,Shusaku Tsumoto,Tsau Y. Lin designed to involve the therapeutic index of available therapies or to find new therapy with superior efficacy or diminished treatment-related morbidity. Clinical care attempts to bring to every patient the optimal benefits of existing knowledge derived from the past experiences of clinical researc作者: resilience 時間: 2025-3-25 08:52
Lech Polkowski,Shusaku Tsumoto,Tsau Y. Lint necessarily in conflict as strategies since it is generally agreed that clinical research delivers best cancer care. Increasingly, cancer clinical research is striving to involve community oncologists so as to increase their ability to study critical questions within a context of optimal care delivery.作者: 雪白 時間: 2025-3-25 13:40 作者: Postmenopause 時間: 2025-3-25 15:55 作者: 外觀 時間: 2025-3-25 22:25
d government who have been intimately concerned with the identification and study of new anticancer drugs. The Chemotherapy Program of the National Cancer In- stitute has represented the major focus of initial efforts in drug development, as summarized in the historical perspective presented in chap作者: 修正案 時間: 2025-3-26 01:04
https://doi.org/10.1007/978-1-4612-1518-9expressed here concerning anticancer chemotherapy represent the result of 20 years of involvement in clinical research including day-to-day working experience with the drug development program of the National Cancer Institute (NCI) and pharmaceutical industries.作者: RACE 時間: 2025-3-26 05:22 作者: HATCH 時間: 2025-3-26 09:39 作者: grandiose 時間: 2025-3-26 14:08
Anatomic and Surgical Principles in Cancer Clinical Trials, location and bulk of the tumor and the pattern of metastasis. These anatomic aspects often define which therapeutic modalities are potentially applicable and delineate the limits of therapy. Surgical participation in trials, necessary in the design and implementation of a trial, is needed in diagnosis, staging, follow-up, and therapy.作者: HAUNT 時間: 2025-3-26 18:48 作者: SLING 時間: 2025-3-26 23:55 作者: 同來核對 時間: 2025-3-27 03:32
The Phase I Study: General Objectives, Methods, and Evaluation,ainly, drug therapy remains the most promising avenue of research for the cure of metastatic cancer at the present time. Consequently, the evaluation of new antitumor agents is an endeavor with the highest priority.作者: dithiolethione 時間: 2025-3-27 05:46
Non-Linearly Variable Thickness Disks,. On the other hand, considering the enormous progress that remains to be achieved in cancer chemotherapy, the most serious failure of a phase II trial is to reject a useful compound. Once a drug is labeled inactive, future development is unlikely.作者: Toxoid-Vaccines 時間: 2025-3-27 12:31
Clinical Evaluation of Anticancer Treatments: Phase II Clinical Trials,. On the other hand, considering the enormous progress that remains to be achieved in cancer chemotherapy, the most serious failure of a phase II trial is to reject a useful compound. Once a drug is labeled inactive, future development is unlikely.作者: JAMB 時間: 2025-3-27 16:37
Mathematical Model of a Gas Journal Bearingntibiotic use. Such a system would allow (1) the rapid screening of potential antineoplastic agents, which would aid in the development of promising clinical trials; and (2) the selection of an appropriate chemotherapeutic agent or agents for an individual patient’s tumor.作者: Ankylo- 時間: 2025-3-27 21:19 作者: Keratin 時間: 2025-3-28 01:08
Biegekritische Drehzahlen zweiter Art,ainly, drug therapy remains the most promising avenue of research for the cure of metastatic cancer at the present time. Consequently, the evaluation of new antitumor agents is an endeavor with the highest priority.作者: 大看臺 時間: 2025-3-28 05:54
Book 1987ncolo- gists‘ approach to the clinical problem of cancer. Therefore, we hope that this book will introduce readers to treatment research in clinical oncology. For the oncologist, the clinical evaluation of antitumor therapy is both part of the day-to-day management of specific patients and the criti作者: 幸福愉悅感 時間: 2025-3-28 06:58
in most oncolo- gists‘ approach to the clinical problem of cancer. Therefore, we hope that this book will introduce readers to treatment research in clinical oncology. For the oncologist, the clinical evaluation of antitumor therapy is both part of the day-to-day management of specific patients and the criti978-1-4612-9425-2978-1-4613-2317-4作者: tendinitis 時間: 2025-3-28 11:34 作者: 行業(yè) 時間: 2025-3-28 16:40 作者: 鉤針織物 時間: 2025-3-28 20:35 作者: tympanometry 時間: 2025-3-29 00:09 作者: 驚呼 時間: 2025-3-29 07:08
Clinical Evaluation: Biochemical Methods,t in or on malignant neoplastic cells and that could be used to diagnose cancer. This has proven to be an elusive goal. Indeed, the existence of “tumor-specific” cellular constituents is still debated. Nevertheless, the presence of a number of “tumor-associated” substances is well established. Altho作者: ORBIT 時間: 2025-3-29 10:34
Anatomic and Surgical Principles in Cancer Clinical Trials,stic factors. This chapter will discuss the importance of these principles in the design and analysis of clinical trials. Anatomic aspects include the location and bulk of the tumor and the pattern of metastasis. These anatomic aspects often define which therapeutic modalities are potentially applic
